USHIFU, LLC ("US HIFU") is a privately held health care company focused on treating primary and recurrent prostate cancer using HIFU, a minimally invasive outpatient procedure which potentially improves patients’ quality of life. US HIFU was founded in 2004 and is headquartered in Charlotte, N.C.

HIFU Around the World

The company is focused on becoming a global market leader utilizing HIFU to revolutionize the delivery of minimally invasive patient care. US HIFU has established partnerships and relationships throughout the world, creating an extensive international presence by making HIFU technology available outside the U.S. in Central America, South America, Canada, India and the Caribbean.

HIFU in the United States
US HIFU is also managing the process of conducting FDA U.S. clinical trials of the Sonablate^® 500, including a trial for primary prostate cancer patients and a trial for patients who have experienced radiation failure.

Clinical Trials in US
For more information about clinical trials that are enrolling patients for treating localized prostate cancer with high intensity focused ultrasound, click here.